Research and Studies. Subject to Pfizer’s prior written approval (which may be provided or withheld in Pfizer’s sole discretion), Licensee may conduct basic research or pre-clinical, clinical or other studies (including Clinical Trials) with the Compound, Product or Licensed Product. For the avoidance of doubt, Pfizer shall have the right to review the study design, specifications, protocol and related materials of any such proposed studies. In the event that any such studies have been approved by Pfizer, Licensee will pay for any necessary supplies, and Licensee agrees to fully comply with all Applicable Law in connection with such Clinical Trials. Unless specified otherwise in a writing signed by Pfizer, Pfizer will not be the sponsor or hold regulatory responsibility for such Clinical Trials and Licensee, pursuant to Section 9.3(a), shall indemnify Pfizer for any liability arising, directly or indirectly, from or based on the conduct of any Clinical Trial or study. Without limiting the foregoing, in the event Pfizer approves any such studies or trials in accordance with this Section 3.3, then, at the option of Pfizer, Pfizer may, but shall have no obligation to, have its representative review any approved studies, but in no event will such activities relieve the sponsor of such Clinical Trials from their oversight and monitoring obligations.
Research and Studies. Licensee shall not conduct basic research or pre-clinical, clinical or other studies (including Clinical Trials, non-clinical toxicology studies or any other study in humans or animals) with the Compound or Licensed Product without Shionogi's prior written approval (which may be provided or withheld in Shionogi's sole discretion). For the avoidance of doubt, Shionogi shall have the right to review the study design, specifications, protocol and related materials of any such proposed studies. In the event that any such studies have been approved by Shionogi, Licensee will pay for any necessary supplies, and Licensee agrees to fully comply with all Applicable Law in connection with such Clinical Trials. Unless specified otherwise in a writing signed by Shionogi, Shionogi will not be the sponsor or hold regulatory responsibility for such Clinical Trials and Licensee, pursuant to Section 9.3(a), shall indemnify Shionogi for any liability arising, directly or indirectly, from or based on the conduct of any Clinical Trial or study. Without limiting the foregoing, in the event Shionogi approves any such studies or trials in accordance with this Section 3.3, then, at the option of Shionogi, Shionogi may, but shall have no obligation to, have its representative review any approved studies, but in no event will such activities relieve the sponsor of such Clinical Trials from their oversight and monitoring obligations.
Research and Studies. The Parties, through the Bilateral Management Committee, will:
a) Proactively identify research needs in support of Bilateral Water Management, including but not limited to research on climate change and other external anthropogenic influences that could affect Bilateral Water Management;
b) Explore opportunities to conduct research jointly, and/or in collaboration with others, including Indigenous governments and organizations, on a case-by-case basis and identify Basin-level research priorities for consideration by the Board;
c) Consider the results of relevant research and studies in Bilateral Water Management.
Research and Studies. The Parties, through the Bilateral Management Committee, will:
a) Proactively identify research needs in support of Bilateral Management, including but not limited to research on climate change and other external anthropogenic influences that could affect Bilateral Management;
b) Explore opportunities to conduct research jointly, and/or in collaboration with others, on a case by case basis and identify basin-level research priorities for consideration by the Board;
c) Consider the results of relevant research and studies in Bilateral Management.
Research and Studies. The Parties, through the Bilateral Management Committee, in recognition that climate change is causing significant effects in the Peel and Mackenzie Delta sub-basin, will:
a) Proactively identify research needs using scientific, traditional and local knowledge and through Learning Plans in support of Bilateral Water Management, including but not limited to research on climate change and other external anthropogenic influences that could affect Bilateral Water Management;
b) Explore opportunities to conduct research jointly, and/or in collaboration with others, including Indigenous Governments and Organizations, on a case-by-case basis and identify Basin-level research priorities for consideration by the Board;
c) Consider the results of relevant research and studies in Bilateral Water Management.
Research and Studies. Carrying out studies and technical audits.
1. Primary Health Care Services. Improving access to quality primary health care services, rehabilitating, equipping, and supplying water to selected health facilities.
Research and Studies. Carrying out studies and technical audits. Part B: Strengthening the Delivery of Priority Health Services
1. Primary Health Care Services. Improving access to quality primary health care services, rehabilitating, equipping, and supplying water to selected health facilities.
Research and Studies. Every now and then information obtained from this service, throughout the sessions and from information you have provided either verbally or in written form, may be used for research and study purposes. If this occurs all corresponding identification about you and your situation will remain confidential. These are designed to help research in the field such as numbers, ages and areas of concern to ensure the industry moves forward.
Research and Studies. Research and studies, except for project evaluation under section II.C.10. “Project evaluation”.
Research and Studies
